Atomic Invest LLC has filed its Form 13F-HR with the Securities and Exchange Commission, disclosing its equity securities portfolio as of the close of business on March 31, 2026. The filing lists the firm's principal executive office as 107 Greenwich Street, 21st Floor, New York, NY 10006, and identifies Erin Harris as the Deputy Chief Compliance Officer responsible for the report.
The information table accompanying the filing details a total of 356 holdings. The portfolio is dominated by exchange-traded funds (ETFs), which comprise the vast majority of the positions listed. Notable individual stock positions include Apple Inc., which is held in 590 shares, and Microsoft Corp., held in 212 shares. Other significant individual holdings include Abbott Laboratories (89 shares), Broadcom Inc. (192 shares), and Eli Lilly and Company (52 shares).
The filing also reveals substantial exposure to cryptocurrency-related funds. The portfolio includes positions in the Bitwise Ethereum ETF (2,574 shares), the Bitwise Solana Staking ETF (1,475 shares), and the Bitwise 10 Crypto Index Fund (127 shares). Additionally, Atomic Invest holds shares in the iShares Bitcoin Trust (173,165 shares) and the iShares Ethereum Trust (288,754 shares).
Bond and fixed-income exposure is represented through various ETFs, including the iShares U.S. Treasury Bond ETF (13,946 shares) and the iShares Core S&P 500 ETF (2,516 shares). The filing indicates that all positions are held for investment purposes, with no indication of voting rights or dispositive power attached to the shares.
